Deficient expression of Bruton's tyrosine kinase in monocytes from X- linked agammaglobulinemia as evaluated by a flow cytometric analysis and its clinical application to carrier detection

Blood

Volumn 91, Issue 2, 1998, Pages 595-602

  Futatani, Takeshi ^b   Miyawaki, Toshio ^a   Tsukada, Satoshi ^b   Hashimoto, Shoji ^b   Kunikata, Toshio ^b   Arai, Shigeyuki ^b   Kurimoto, Masashi ^b   Niida, Yo ^b   Matsuoka, Hiroshi ^b   Sakiyama, Yukio ^b   Iwata, Tsutomu ^b   Tsuchiya, Shigeru ^b   Tatsuzawa, Osamu ^b   Yoshizaki, Kazuyuki ^b   Kishimoto, Tadamitsu ^b  

^a UNIVERSITY OF TOYAMA   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN TYROSINE KINASE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME DEFICIENCY; FLOW CYTOMETRY; GENETIC LINKAGE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MISSENSE MUTATION; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; X LINKED AGAMMAGLOBULINEMIA;

ADOLESCENT; ADULT; AGAMMAGLOBULINEMIA; CHILD; CHILD, PRESCHOOL; FEMALE; FLOW CYTOMETRY; HUMANS; LINKAGE (GENETICS); MONOCYTES; MUTATION; PROTEIN-TYROSINE KINASES; X CHROMOSOME;

EID: 19244372556     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Bruton COC: Agammaglobulinemia. Pediatrics 9:722, 1952
2. Rosen FS, Cooper MD, Wedgwood RJP: The primary immunodeficiencies. N Engl J Med 333:431, 1995
3. Lederman HM, Winkelstein JA: X-linked agammagtobulinemia. An analysis of 96 patients. Medicine 64:145, 1985
4. Ochs HD, Smith CIE: X-linked agammaglobulinemia. A clinical and molecular analysis. Medicine 75:287, 1996
5. Khan WN, Sideras P, Rosen FS, Alt FW: The role of Bruton's tyrosine kinase in B-cell development and function in mice and man. Ann NY Acad Sci 764:27, 1995
6. Kwan S-P, Kunkel L, Bruns G, Wedgwood RJ, Latt S, Rosen FS: Mapping of the X-linked agammaglobulinemia locus by use of restriction fragment-length polymorphism. J Clin Invest 77:649, 1986
7. Vetrie D, Vorechovsky I, Sideras P, Holland J, Davies A, Flinter F, Hammarström L, Kinnon C, Levinsky R, Bobrow M, Smith CIE, Bentley DR: The gene involved in X-linked agammaglobulinemia is a member of the src family of protein-tyrosine kinases. Nature 361:226, 1993
8. Tsukada S, Saffran DC, Rawlings DJ, Parolini O, Allen RC, Klisak I, Sparkes RC, Kubagawa H, Mohandas T, Quan S, Belmont JW, Cooper MD, Conley ME, Witte ON: Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia. Cell 72:279, 1993
9. Tsukada S, Rawlings DJ, Witte ON: Role of Bruton's tyrosine kinase in immunodeficiency. Curr Opin Immunol 6:623, 1994
10. Sideras P, Smith CIE: Molecular and cellular aspects of X-linked agammaglobulinemia. Adv Immunol 59:135, 1995
11. Ohta Y, Haire RN, Litman RT, Fu SM, Nelson RP, Kratz J, Kornfeld SJ, de la Morena M, Good RA, Litman GW: Genomic organization and structure of Bruton agammaglobulinemia tyrosine kinase: Localization of mutations associated with varied clinical presentations and course in X chromosome-inked agammaglobulinemia. Proc Natl Acad Sci USA 91:9062, 1994
12. Sideras P, Müller S, Shiels H, Jin H, Khan WN, Nilsson I, Parkinson E, Thomas JD, Branden L, Larrson I, Paul WE, Rosen FS, Alt FW, Vetrie D, Smith CIE, Xamhopoulos KG: Genomic organization of mouse and human Bruton's agammaglobulinemia tyrosine kinase (Btk) loci. J Immunol 153:5607, 1994
13. Hagemann TL, Chen Y, Rosert FS, Kwan SP: Genomic organization of the Btk gene and exon scanning for mutations in patients with X-linked-agammaglobulirtemia. Hum Mol Genet 3:1743, 1994
14. Rohrer J, Parolini O, Belmont JW, Conley ME: The genomic structure of human BTK, the defective gene in X-linked agammaglobulinemia. Immunogenetics 40:319, 1994
15. Vihinen M, Belohradsky BH, Haire RN, Holinsk-Feder E, Kwan S-P, Lappalainen I, Lehväslaiho H, Lester T, Meindl A, Ochs HD, Ollila J, Vorechovsky I, Weiss M, Smith CIE: BTKbase, mutation database for X-linked agammaglobulinemia (XLA). Nucleic Acids Res 25:166, 1997
16. Saffran, DC, Parolini O, Fitch-Hilgenberg ME, Rawlings DJ, Afar DEH, Witte ON, Conley ME: Brief report: A point mutation in the SH2 domain of Bruton's tyrosine kinase in atypical X-linked agammaglobulinemia. N Engl J Med 330:1488, 1994
17. Conley ME, Fitch-Hilgenberg ME, Cleveland JL, Parolini O, Rohrer J: Screening of genomic DNA to identify mutations in the gene for Bruton's tyrosine kinase. Hum Mol Genet 3:1751, 1994
18. Hashimoto S, Tsukada S, Matsushita M, Miyawaki T, Niida Y, Yachie A, Kobayashi S, Iwata T, Hayakawa H, Matsuoka H, Tsuge I, Yamadori T, Kunikata T, Arai S, Yoshizaki K, Taniguchi N, Kishimoto T: Identification of Bruton's tyrosine kinase (Btk) gene mutations and characterization of the derived proteins in 35 X-linked agammaglobulinemia families: A nationwide study of Btk deficiency in Japan. Blood 88:561, 1996
19. Bykowsky MJ, Haire RN, Ohta Y, Tang H, Sung S-SJ, Veksler ES, Greene JM, Fu SM, Litman GW, Sullivan KE: Discordant phenotype in siblings with X-linked agammaglobulinemia. Am J Hum Genet 58:477, 1996
20. 145→stop) in Bruton's tyrosine kinase is associated with newly diagnosed X-linked agammaglobulinemia in a 51-year-old male. Mol Med 2:619, 1996
21. Conley ME, Brown P, Pickard, AR, Buckley RH, Miller DS, Raskind WH, Singer JW, Fialkow PJ: Expression of the gene defect in X-linked agammaglobulinemia. N Engl J Med 315:564, 1986
22. Conley ME, Puck JM: Carrier detection in typical and atypical X-linked agammaglobulinemia. J Pediatr 112:688, 1988
23. Fearon ER, Winkelstein JA, Civin CI, Pardoll DM, Vogelstein B: Carrier detection in X-linked agammaglobulinemia by analysis of X-chromosome inactivation. N Engl J Med 316:427, 1987
24. De Weers M, Verschuren MCM, Kraakman ME, Mensink RGJ, Schuurman RKB, van Dongen JJM, Hendriks RW: The Bruton's tyrosine kinase gene is expressed throughout B cell differentiation, from early precursor B cell stages preceding immunoglobulin gene rearrangement up to mature B cell stages. Eur J Immunol 23:3109, 1993
25. Smith CIE, Baskin B, Humire-Greiff P, Zhou J, Olsson PG, Maniar HS, Kjellén P, Lambris JD, Christensson B, Hammarström L, Bentley D, Vetrie D, Islam KB, Vorechovsky I, Sideras P: Expression of Bruton's agammaglobulinemia tyrosine kinase gene, BTK, is selectively down-regulated in T lymphocytes and plasma cells. J Immunol 152:557, 1994
26. Kobayashi S, Iwata T, Saito M, Iwasaki R, Matsumoto H, Narikata S, Kono Y, Hayashi Y: Mutations of the Btk gene in 12 unrelated families with X-linked agammaglobulinemia in Japan. Hum Genet 97:424, 1996
27. Ohashi Y, Tsuchiya S, Konno T: A new point mutation involving a highly conserved leucine in the Btk SH2 domain in a family with X linked agammaglobulinemia. J Med Genet 32:77, 1995
28. Iwai K, Miyawaki T, Takizawa T, Konno A, Ohta K, Yachie A, Seki H, Taniguchi N: Differential expression of bcl-2 and susceptibility to anti-Fas-mediated cell death in peripheral blood lymphocytes, monocytes, and neutrophils. Blood 84:1201, 1994
29. + T-lymphocytes in acute infectious mononucleosis supporting their susceptibility to programmed cell death. Blood 82:521, 1993
30. Jeanpierre M: Germinal mosaicism and risk calculation in X-linked diseases. Am J Hum Genet 50:960, 1992
31. Busque L, Mio R, Mattioli M, Brais E, Lalonde Y, Maragh M, Gilliland DG: Nonrarndom X-inactivation patterns in normal females: Lyonization ratios vary with age. Blood 88:59, 1996
32. Genevier HC,Hinshelwood S, Gaspar HB, Rigley KP, Brown D, Saeland S, Rousset F, Levinsky RJ, Callard RE, Kinnon C, Lovering RC: Expression of Burton's tyrosine kinase protein within the B cell lineage. Eur J Immunol 24:3100, 1994
33. Stewart DM, Kurman CC, Nelson DL: Production of monoclonal antibodies to Breton's tyrosihe kinase. Hybridoma 14:243, 1995
34. Vihinen M, Vetrie D, Maniar HS, Ochs HD, Zhou Q, Vorechovsky, Webster ADV, Notarangelo LD, Nilsson L, Sawadski JM: Structural basis for chromosome X-linked agammaglobulinemia: A tyrosine kinase disease. Proc Natl Acad Sci USA 91:12803, 1994
35. Muhlrad D, Parker R: Premature transnational termination triggers mRNA decapping. Nature 370:578, 1994
36. Aoufouchi S, Yélamos J, Milstein C: Nonsense mutations inhibit RNA splicing in a cell-free system: Recognition of mutant codon is independent of protein synthesis. Cell 85:415, 1996
37. Kolluli R, Tolias KF, Carpenter CL, Rosen FS, Kirchhausen T: Direct interaction of the Wiskott-Aldrich syndrome protein with the GTPase Cdc42. Proc Natl Acad Sci USA 93:5615, 1996
38. Rawlings DJ, Saffran DC, Tsukada S, Largaespada DA, Grimaldi JC, Cohen L, Mohr RN, Bazan JF, Howard M, Coperfand NG, Jenkins NA, Witte ON: Mutation of unique region of Bruton's tyrosine kinase in immunodeficient XID mouse. Science 261:358, 1993
39. Fukuda M, Kojima T, Kabayama H, Mikoshiba K: Mutation of the pleckstrin homolpgy domain of Bruton's tyrosine kinase in immunodeficiency impaired inositol 1,3,4,5-tetrakisphophate binding capacity. J Biol Chem 271:30303, 1996
40. Yao L, Kawakami Y, Kawakami T: The pleckstrin homoiogy domain of Bruton tyrosine kinase interacts with protein kinase C. Proc Natl Acad Sci USA 91:9079, 1994